ATLANTA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and ...
On September 29, 2025, Dogwood Therapeutics, Inc. (NASDAQ:DWTX) announced a royalty-free, global license deal with Serpin Pharma for SP16 for the management of cancer related pain (CRP), including a ...
A line drawing of the Internet Archive headquarters building façade. An illustration of a magnifying glass. An illustration of a magnifying glass.
Shares of US clinical-stage biotech Dogwood Therapeutics (Nasdaq: DWTX) soared a massive 43% to $7.91 yesterday, on the news it has secured a royalty free, global license to develop Serpin Pharma’s ...
ATLANTA - Dogwood Therapeutics, Inc. (NASDAQ:DWTX), a clinical-stage biotech company with a market capitalization of $10.55 million, has secured a royalty-free global license for Serpin Pharma’s SP16, ...
Dimplex SP16 Operating instructions Topics manualzilla, manuals, Old, Home building and Decor, Indoor Fireplace, , Collection manuals_contributions; manuals; additional_collections Item Size 23.1M ...